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PreviewsArrestins are a family of scaffolding 
proteins that are closely associated 
with the function of seven transmem-
brane domain G protein-coupled 
receptors (GPCRs). In mammals, two 
members of the arrestin family, the 
visual arrestins, are restricted to pho-
toreceptor cells, whereas two others, 
β-arrestin 1 and β-arrestin 
2, are expressed ubiq-
uitously. These proteins 
promote the internaliza-
tion and desensitization of 
GPCRs (Ferguson et al., 
1996; Lohse et al., 1990). 
Following agonist-induced 
phosphorylation of GPCRs 
by kinases, arrestins move 
from the cytoplasm to the 
plasma membrane and 
bind to the phosphorylated 
receptors. The interaction 
of arrestins with phos-
phorylated GPCRs leads 
to an uncoupling of G pro-
tein-dependent receptor 
signaling (receptor desen-
sitization). Arrestins also 
promote receptor inter-
nalization by recruiting the 
endocytic machinery. How-
ever, recently it has become 
evident that the biological 
functions of arrestins go 
well beyond these well-
established roles.
It is becoming clear that 
arrestins promote signal 
transduction by GPCRs. 
Both β-arrestin 1 and β-
arrestin 2 act as molecular 
scaffolds that recruit sig-
naling molecules such as kinases and 
phosphatases to the activated recep-
tors (Beaulieu et al., 2005; Luttrell 
et al., 1999; Shenoy and Lefkowitz, 
2003). Formation of β-arrestin-based 
signaling complexes facilitates the acti-
vation and/or inhibition of these signal-
ing molecules (Shenoy and Lefkowitz, 
2003). The scaffolding/signaling func-
tions of β-arrestins have been stud-
ied extensively in heterologous and 
homologous cellular systems, and in 
vivo a β-arrestin 2/PP2A/Akt signaling 
complex is critical for D2 dopamine 
receptor-dependent behaviors in mice 
(Beaulieu et al., 2005).
During development, β-
arrestins may have a role 
in signaling by the seven 
transmembrane domain 
receptor proteins frizzled 
and smoothened (Chen et 
al., 2004). β-arrestins trans-
locate to these receptors in 
a phosphorylation-depen-
dent manner. In zebrafish, 
downregulation of β- 
arrestin 2 results in a disrup-
tion of hedgehog/patched/
smoothened function dur-
ing development (Wilbanks 
et al., 2004), suggesting 
that β-arrestins act either 
as positive regulators or as 
mediators of signaling in 
these systems.
In this issue of Cell, Kang 
et al. (2005) have uncovered 
yet another unexpected 
function of arrestins. Since 
their initial characterization, 
arrestins have been thought 
of as cytoplasmic proteins 
that could be recruited to 
the plasma membrane and 
endocytic compartments 
following receptor activa-
tion. Although β-arrestin 2 
and visual arrestins appear 
to be found exclusively in 
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Arrestins have important roles in the cytoplasm and at the plasma membrane, including the 
desensitization and internalization of G protein-coupled receptors (GPCRs). In this issue of 
Cell, Kang et al. (2005) provide evidence that β-arrestin 1 moves to the nucleus in response 
to GPCR stimulation, where it regulates gene expression by facilitating histone acetylation 
at specific gene promoters.
Figure 1. Model for the Regulation of Histone Acetylation 
and Gene Transcription by β-Arrestin in Response to GPCR 
Activation
Stimulation of d- and κ-opioid receptors and potentially other GPCRs re-
sults in enhanced translocation of β-arrestin 1 to the nucleus and its asso-
ciation with specific promoter regions such as those for the c-fos and p27 
genes. β-arrestin 1 in the nucleus acts as a scaffold for a protein complex, 
which includes the CREB transcription factor, the histone acetyltransfer-
ase p300, and other unidentified proteins. Recruitment of p300 to specific 
promoter regions by β-arrestin 1 results in acetylation (Ac) of histone H4 
leading to chromatin reorganization and enhanced gene transcription.Cell 123, December 2, 2005 ©2005 Elsevier Inc. 755
the cytoplasm, β-arrestin 1 has been 
shown to reside in both the cytoplasm 
and the nucleus (Scott et al., 2002; 
Wang et al., 2003), thus suggesting 
that at least one member of this fam-
ily may also have a nuclear function. 
Intrigued by this possibility, Kang et al. 
(2005) assessed the impact of GPCR 
stimulation on β-arrestin 1 distribu-
tion and showed that in transfected 
fibroblasts, β-arrestin 1 translocates 
to the nucleus in response to activa-
tion of two prototypical GPCRs, the κ- 
and d-opioid receptors. Furthermore, 
translocation of β-arrestin 1 to the 
nucleus correlated with an increase in 
the expression of two genes involved 
in the regulation of cell proliferation, 
the transcription factor c-fos and the 
cyclin-dependent kinase inhibitor p27/
kip1. Activation of κ-opioid receptors 
also leads to an increase in the level 
of p27 protein that is dependent on 
nuclear β-arrestin 1. A thorough char-
acterization of the molecular events by 
which β-arrestin 1 contributes to the 
regulation of these two genes revealed 
that β-arrestin 1 participates in the 
formation of a nuclear complex on 
the promoter regions of the p27 and 
c-fos genes. This complex includes 
the transcription factor CREB and 
the histone acetyltransferase p300. 
β-arrestin 1 does not appear to be 
essential for the binding of CREB to 
c-fos and p27 gene promoters. From 
these data, the authors suggest that 
β-arrestin 1 acts as a nuclear scaffold 
that recruits p300 to CREB. This leads 
to increased acetylation of histone H4 
and the reorganization of chromatin, 
thereby increasing gene expression 
(Figure 1).
The results of Kang et al. (2005) are 
potentially groundbreaking because 
they introduce a completely new 
function for arrestins and a new mode 
by which GPCRs may regulate gene 
transcription. GPCR signaling through 
traditional G protein-dependent and 
second messenger cascades have 
previously been shown to regulate 
gene expression, and these pathways 
presumably regulate histone modi-
fication and chromatin remodeling 
(Chao and Nestler, 2004). However, 
the involvement of β-arrestin in medi-756 Cell 123, December 2, 2005 ©2005 ating GPCR regulation of transcription 
may be required in certain physiologi-
cal situations. An interesting distinc-
tion that has become apparent from 
cellular and in vivo studies is that β-
arrestin-dependent GPCR signaling 
lasts longer than conventional G pro-
tein-dependent signaling (Ahn et al., 
2004; Beaulieu et al., 2005). Thus, the 
β-arrestin-dependent mechanism for 
transcriptional control as proposed 
by Kang et al. (2005), may be used 
under certain physiological situations 
when sustained signaling is needed.
As with any provocative new find-
ings, the model proposed by Kang 
et al. (2005) raises multiple questions 
that may fuel research for years to 
come. A major question concerns to 
what extent this mechanism is used 
by GPCRs. The authors have limited 
their observations to a few GPCRs. d- 
and κ-opioid receptors trigger nuclear 
accumulation of β-arrestin 1, whereas 
stimulation of µ-opioid and β-adren-
ergic receptors do not. However, it is 
highly possible that other GPCRs and 
perhaps non-GPCR receptors may 
also trigger translocation of β-arrestin 
1 to the nucleus. In this regard, it is 
particularly intriguing from the results 
presented by Kang et al. (2005) that 
both c-fos and p27 gene expres-
sion were affected by changes in the 
expression of β-arrestin 1 whereas 
only p27 expression was clearly 
affected by d-opioid receptor stimula-
tion. This suggests that other receptor 
systems participate in the regulation of 
c-fos expression by β-arrestin 1. Simi-
larly, it is an open and rather obvious 
question whether c-fos and p27 are 
the only two genes that can be regu-
lated by β-arrestin 1. One would think 
that β-arrestin 1 mediates widespread 
changes in gene expression.
Another question concerns the 
mechanisms by which β-arrestin 1 
nuclear complexes are formed. Kang 
et al. (2005) state that a preliminary 
proteomic characterization of the com-
plex indicates the presence of other 
proteins in addition to β-arrestin 1, 
CREB, and p300. Characterization of 
these proteins may reveal other direct 
interacting partners of β-arrestin 1 and 
could suggest a mechanism by which Elsevier Inc.GPCRs regulate β-arrestin 1 transloca-
tion to the nucleus and gene expres-
sion. Another particularly interesting 
aspect of the mechanism proposed 
by Kang et al. (2005) is that recep-
tors may not be part of the nuclear 
complex they describe, thus raising 
the tantalizing possibility that arres-
tins may act as molecular scaffolds in 
the absence of receptors. β-arrestins 
have been shown to act as scaffolds 
for multiple signaling kinases, some of 
which, like Erk and Akt, are known to 
undergo nuclear translocation (Beau-
lieu et al., 2005; Luttrell et al., 1999). 
Thus, it would be interesting to deter-
mine whether nuclear β-arrestin 1 can 
act as a scaffold for the phosphoryla-
tion of nuclear proteins in addition to 
modulating histone acetylation.
Finally, as with any work conducted 
in heterologous cellular systems, it 
is uncertain under which conditions 
the new nuclear function of β-arres-
tin 1 will be physiologically relevant. 
Although the authors make a valiant 
effort to evaluate the impact of d-
opioid receptor stimulation upon p27 
expression and histone H4 acetylation 
at the p27 promoter in the brain, more 
detailed studies will be required to 
clearly establish the role of β-arrestin 
1 in these processes in vivo. Moreover, 
the absence of an overt developmen-
tal phenotype in β-arrestin 1 knockout 
mice suggests that the role played by 
this protein in gene regulation under 
physiological conditions may be lim-
ited or compensated by other mecha-
nisms. However, a detailed reexami-
nation of β-arrestin 1 knockout mice 
in light of the observations made by 
Kang et al. (2005) may reveal subtle 
phenotypes and allow the identifica-
tion of as-yet-unrecognized biological 
functions of β-arrestin 1.
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potency (Nichols et al., 1998). Without 
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fail to acquire the potential to differ-
entiate into multiple lineages and are 
restricted to the generation of a single 
lineage, the extraembryonic trophec-
toderm, which eventually gives rise to 
the placenta. Furthermore, continuous 
expression of Oct3/4 is required to 
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of Oct3/4 from ES cells precipitates 
unidirectional differentiation into troph-
ectoderm (Niwa et al., 2000).
Oct3/4 is thus positioned foremost 
in the hierarchy of transcriptional 
determinants of the pluripotent state 
(Chambers and Smith, 2004). One 
key effect of Oct3/4 is to suppress 
differentiation of embryonic cells into 
trophectoderm. Niwa et al. (2005) 
demonstrate that Oct3/4 achieves this 
by blocking both the expression and 
activity of the homeodomain transcrip-
tion factor Cdx2. First, they observed 
that Cdx2 is rapidly upregulated upon 
elimination of Oct3/4 from mouse ES 
cells. Then they found that forced 
expression of Cdx2 is sufficient to 
induce trophoblast differentiation (Fig-
ure 1, lower panel), reproducing the 
effect of removal of Oct3/4. The gene 
expression changes that accompany 
misexpression of Cdx2 or elimination 
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